| 摘要 |
<p>Antagonists at the NMDA receptor complex which are benz[b]azepines of formula (I) having a hydroxy, alkoxy or amino substituent at the 3-position and a 4-position alkenyl, alkynyl, aryl or heteroaryl substituent for treatment of stroke and/or other neurodegenerative disorders.</p> |
